EGFR and ovarian cancer: For the initial assessment of antitumoral NK cell activity in ovarian cancer, we implemented an in vitro coculture system consisting of healthy donor NK cells, EGFR-positive tumor cells, and the anti-EGFR antibody Cetuximab that mediates ADCC (Figure 1B).